These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 22592564)

  • 1. TTR-related amyloid neuropathy: clinical, electrophysiological and pathological findings in 15 unrelated patients.
    Luigetti M; Conte A; Del Grande A; Bisogni G; Madia F; Lo Monaco M; Laurenti L; Obici L; Merlini G; Sabatelli M
    Neurol Sci; 2013 Jul; 34(7):1057-63. PubMed ID: 22592564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotypic and phenotypic presentation of transthyretin-related familial amyloid polyneuropathy (TTR-FAP) in Turkey.
    Durmuş-Tekçe H; Matur Z; Mert Atmaca M; Poda M; Çakar A; Hıdır Ulaş Ü; Oflazer-Serdaroğlu P; Deymeer F; Parman YG
    Neuromuscul Disord; 2016 Jul; 26(7):441-6. PubMed ID: 27238058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis.
    Koike H; Hashimoto R; Tomita M; Kawagashira Y; Iijima M; Tanaka F; Sobue G
    Amyloid; 2011 Jun; 18(2):53-62. PubMed ID: 21463231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late-onset familial amyloid polyneuropathy (FAP) Val30Met without family history.
    Rudolph T; Kurz MW; Farbu E
    Clin Med Res; 2008 Sep; 6(2):80-2. PubMed ID: 18606975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variable presentations of TTR-related familial amyloid polyneuropathy in seventeen patients.
    Cappellari M; Cavallaro T; Ferrarini M; Cabrini I; Taioli F; Ferrari S; Merlini G; Obici L; Briani C; Fabrizi GM
    J Peripher Nerv Syst; 2011 Jun; 16(2):119-29. PubMed ID: 21692911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features of familial amyloid polyneuropathy carrying transthyretin mutations in four Chinese kindreds.
    Liu G; Ni W; Wang H; Li H; Zhang Y; Wang N; Wu Z
    J Peripher Nerv Syst; 2017 Mar; 22(1):19-26. PubMed ID: 27859927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and genetic findings in eight Israeli patients with transthyretin-associated familial amyloid polyneuropathy.
    Leibou L; Frand J; Sadeh M; Lossos A; Kremer E; Livneh A; Yarnitsky D; Herman O; Dabby R
    Isr Med Assoc J; 2012 Nov; 14(11):662-5. PubMed ID: 23240369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late-onset Transthyretin (TTR)-familial Amyloid Polyneuropathy (FAP) with a Long Disease Duration from Non-endemic Areas in Japan.
    Miyake Z; Nakamagoe K; Ezawa N; Yoshinaga T; Hashimoto R; Sato T; Sekijima Y; Tamaoka A
    Intern Med; 2019 Mar; 58(5):713-718. PubMed ID: 30333406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common clinicopathological features in late-onset hereditary transthyretin amyloidosis (Ala97Gly, Val94Gly and Val30Met).
    Koike H; Nakamura T; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Yasuda T; Mukai E; Date Y; Shiomi K; Nakazato M; Katsuno M; Sobue G
    Amyloid; 2019; 26(sup1):24-25. PubMed ID: 31343348
    [No Abstract]   [Full Text] [Related]  

  • 10. Transthyretin-related familial amyloid polyneuropathy (ATTR-FAP) in Poland - genetic and clinical presentation.
    Lipowska M; Drac H; Rowczenio D; Gilbertson J; Hawkins PN; Lasek-Bal A; Szewczuk J; Grzybowski J; Gawor M; Stępień-Wojno M; Franaszczyk M; Brydak-Godowska J; Śmierciak R; Ptasińska-Perkowska A; Chandoga J; Petrovic R; Kostera-Pruszczyk A
    Neurol Neurochir Pol; 2020; 54(6):552-560. PubMed ID: 33373035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP).
    Planté-Bordeneuve V; Ferreira A; Lalu T; Zaros C; Lacroix C; Adams D; Said G
    Neurology; 2007 Aug; 69(7):693-8. PubMed ID: 17698792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features.
    Misu Ki; Hattori N; Nagamatsu M; Ikeda Si; Ando Y; Nakazato M; Takei Yi; Hanyu N; Usui Y; Tanaka F; Harada T; Inukai A; Hashizume Y; Sobue G
    Brain; 1999 Oct; 122 ( Pt 10)():1951-62. PubMed ID: 10506096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor Yield of Routine Transthyretin Screening in Patients with Idiopathic Neuropathy.
    Namiranian D; Chalk C; Massie R
    Can J Neurol Sci; 2020 Nov; 47(6):816-819. PubMed ID: 32493526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transthyretin Familial Amyloid Polyneuropathy - Disease Profile of a Multisystem Disorder].
    Niemietz C; Röcken C; Schilling M; Stypmann J; Uhlig CE; Schmidt HH
    Dtsch Med Wochenschr; 2018 Mar; 143(6):427-430. PubMed ID: 29544239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-centre experience on transthyretin familial amyloid polyneuropathy: case series and literature review.
    Martens B; De Pauw M; De Bleecker JL
    Acta Neurol Belg; 2018 Jun; 118(2):179-185. PubMed ID: 29524093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity.
    Ikeda S; Nakazato M; Ando Y; Sobue G
    Neurology; 2002 Apr; 58(7):1001-7. PubMed ID: 11940682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological parameters that contribute to the pathogenesis of familial amyloid polyneuropathy caused by transthyretin mutations.
    Lai HJ; Lai WT; Jin L; Kuo KT; Lee MJ
    J Neurol Sci; 2020 Jun; 413():116810. PubMed ID: 32247966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and pathological findings in familial amyloid polyneuropathy caused by a transthyretin E61K mutation.
    Murakami T; Nishimura H; Nagai T; Hemmi S; Kutoku Y; Ohsawa Y; Sunada Y
    J Neurol Sci; 2017 Oct; 381():55-58. PubMed ID: 28991715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy.
    Koike H; Ando Y; Ueda M; Kawagashira Y; Iijima M; Fujitake J; Hayashi M; Yamamoto M; Mukai E; Nakamura T; Katsuno M; Hattori N; Sobue G
    J Neurol Sci; 2009 Dec; 287(1-2):178-84. PubMed ID: 19709674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Family dynamics in transthyretin-related familial amyloid polyneuropathy Val30Met: Does genetic risk affect family functioning?
    Lopes A; Rodrigues C; Fonseca I; Sousa A; Branco M; Coelho T; Sequeiros J; Freitas P
    Clin Genet; 2018 Nov; 94(5):401-408. PubMed ID: 30019395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.